US Stock Market Closed

Dashboard

Merck & Co., Inc. (MRK)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

B

Analyst Opinion

H

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

About

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

CEO

Kenneth C. Frazier

Employees

71,000

Industry

Diversified Biopharmaceuticals

Sector

Healthcare

Headquarters

Kenilworth

Exchange

New York Stock Exchange

Summary Stats

Market Cap

273B

Revenue

57.5B

Net Income

15.3B

EPS

$6.08

Price-to-Earnings

17.68

Price-to-Book

6.13

Debt-to-Equity

1.41

News

Analyst Ratings

Price targets projected by 19 analysts

High

$107.00

Average

$95.89

Low

$85.00

Ratings calculated by 22 analysts

Buy

17

Hold

5

Sell

0

Last Dividend

Amount

$0.69

Dividend Date

Frequency

quarterly

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Above by $0.10

Actual

$1.85 +5.7%

Consensus

1.75

Report Date

Year Ago

1.75

Year Ago Change %

Up 5%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites